Affordable Access

Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor.

Authors
  • Barbee, R W
  • Perry, B D
  • Ré, R N
  • Murgo, J P
  • Field, L J
Type
Published Article
Journal
Circulation Research
Publisher
Ovid Technologies (Wolters Kluwer Health)
Publication Date
Apr 01, 1994
Volume
74
Issue
4
Pages
747–751
Identifiers
PMID: 8137510
Source
Medline
License
Unknown

Abstract

The circulatory effects associated with lifelong plasma atrial natriuretic factor (ANF) elevation were examined by generating transgenic mice, which constitutively express a fusion gene consisting of the transthyretin promoter and the ANF structural gene. These mice have chronically elevated ANF levels as compared with their nontransgenic siblings. Transgenic animals exhibited immunoreactive ANF levels that were nearly fivefold higher than those measured in nontransgenic littermates. Systemic and regional hemodynamics and blood volumes were explored by using modifications of the reference microsphere and dilution techniques. Mean arterial pressure was reduced by 24 mm Hg, associated with a 27% reduction in total heart weight. This chronic reduction in blood pressure was due to a 21% reduction in total peripheral resistance, whereas cardiac output, stroke volume, and heart rate were not significantly altered, despite a 15% elevation in plasma volume. Transgenic mice displayed reductions of 35%, 33%, 32%, and 19% in muscle, skin, brain, and renal vascular resistance, respectively, whereas coronary and splanchnic resistances were not significantly altered. The findings complement earlier data from chronically infused normotensive mammals and suggest that these mice are an excellent model for investigating the effects of lifelong ANF elevation.

Report this publication

Statistics

Seen <100 times